Sageworth Trust CO Biogen Inc. Transaction History

Sageworth Trust CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 04, 2020	SELL	$264.77 - $305.71 $1,059 - $1,222	-4 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$258.66 - $342.55 $1,034 - $1,370	4 New	4 $1,000
Q2 2019 Jul 19, 2019	SELL	$219.29 - $241.72 $17,104 - $18,854	-78 Closed	0 $0
Q1 2019 Apr 08, 2019	BUY	$216.71 - $338.96 $16,469 - $25,760	76 Added 3800.0%	78 $18,000
Q4 2018 Jan 18, 2019	BUY	$278.5 - $352.75 $557 - $705	2 New	2 $1,000
Q2 2018 Jul 19, 2018	SELL	$257.52 - $306.91 $11,073 - $13,197	-43 Closed	0 $0
Q1 2018 May 03, 2018	BUY	$260.13 - $367.91 $11,185 - $15,820	43 New	43 $12,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Sageworth Trust CO, based on Form 13F filings with the SEC.

Stay updated on Sageworth Trust CO with notifications on news.